Ajooni Biotech profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 4.8% | 4.8% | 5.2% | 5.1% | 2.7% | ||
| 4.0% | 4.0% | 4.7% | 4.6% | 1.9% | ||
| 4.4% | 4.4% | 3.9% | 3.1% | — | ||
| 3.0% | 2.8% | 2.4% | 2.2% | — | ||
Margins | ||||||
| 3.4% | 3.4% | 3.2% | 2.8% | 3.7% | ||
| 2.2% | 2.2% | 2.3% | 1.7% | 2.4% | ||
| — | 2.1% | 3.6% | −7.1% | — | ||
| 2.5% | 3.1% | 3.8% | 3.7% | 2.1% | ||
| 1.8% | 2.4% | 2.9% | 2.7% | 1.5% | ||
| −13.0% | −13.0% | −18.1% | −11.9% | −11.3% | ||
Additional | ||||||
| 26.2% | 24.7% | 22.1% | 27.9% | 28.7% | ||
| 4.8% | 4.8% | 5.2% | 5.1% | 2.7% | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.